10-Q Filing

Processa Pharmaceuticals, Inc. CIK: 1533743 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001493152-21-019495`
Period End Date	20210630
Filing Date	20210812
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 50 Cash Flow Statement 60 Stockholders Equity 28

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	15.60M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.19M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.83M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.19M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	15.60M	shares	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$154.73K	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	-	USD	Point-in-time
Due from tax agencies	`DueFromTaxAgencies`	$77.02K	USD	Point-in-time
Due from tax agencies	`DueFromTaxAgencies`	$70.27K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$554.71K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.66M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$22.57M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$16.20M	USD	Point-in-time
Property and Equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Property and Equipment, net	`PropertyPlantAndEquipmentNet`	$484.00	USD	Point-in-time
Operating lease right-of-use assets, net of accumulated amortization	`OperatingLeaseRightOfUseAsset`	$158.56K	USD	Point-in-time
Operating lease right-of-use assets, net of accumulated amortization	`OperatingLeaseRightOfUseAsset`	$117.24K	USD	Point-in-time
Intangible assets, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$8.45M	USD	Point-in-time
Intangible assets, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$8.85M	USD	Point-in-time
Security deposit	`SecurityDeposit`	$5.54K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$5.54K	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$8.57M	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$9.01M	USD	Point-in-time
Total Assets	`Assets`	$31.14M	USD	Point-in-time
Total Assets	`Assets`	$25.21M	USD	Point-in-time
Note payable Paycheck Protection Program, current portion	`NotesPayableCurrent`	-	USD	Point-in-time
Note payable Paycheck Protection Program, current portion	`NotesPayableCurrent`	$117.57K	USD	Point-in-time
Current maturities of operating lease liability	`OperatingLeaseLiabilityCurrent`	$87.20K	USD	Point-in-time
Current maturities of operating lease liability	`OperatingLeaseLiabilityCurrent`	$92.45K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	-	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$950.00	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$320.69K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$287.88K	USD	Point-in-time
Due to licensor	`DueToLicensor`	$400.00K	USD	Point-in-time
Due to licensor	`DueToLicensor`	$400.00K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$11.74K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$69.86K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$369.11K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$224.68K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.16M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.22M	USD	Point-in-time
Note payable Paycheck Protection Program	`NotesPayable`	-	USD	Point-in-time
Note payable Paycheck Protection Program	`NotesPayable`	$44.88K	USD	Point-in-time
Non-current operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$78.46K	USD	Point-in-time
Non-current operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$30.90K	USD	Point-in-time
Non-current due to licensor	`NoncurrentDueToLicensor`	$400.00K	USD	Point-in-time
Non-current due to licensor	`NoncurrentDueToLicensor`	$400.00K	USD	Point-in-time
Net deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$530.61K	USD	Point-in-time
Net deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$304.19K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.90M	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.27M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.0001, 30,000,000 shares authorized: 15,604,605 and 14,187,984 issued and outstanding at June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$1.42K	USD	Point-in-time
Common stock, par value $0.0001, 30,000,000 shares authorized: 15,604,605 and 14,187,984 issued and outstanding at June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$1.56K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$59.89M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$48.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-25.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-30.65M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$29.24M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$31.34M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$7.23M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$8.01M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$22.94M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$6.59M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$31.14M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$25.21M	USD	Point-in-time

Income Statement 50 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.61M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.09M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$928.86K	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$427.11K	USD	1 Quarter
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	$515.63K	USD	1 Quarter
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	-	USD	2 Qtrs
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	$515.63K	USD	2 Qtrs
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	-	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.33M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$374.88K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.05M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$859.25K	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-801.99K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-5.65M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-3.46M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-1.79M	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	1 Quarter
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	1 Quarter
Interest expense	`InterestExpense`	$36.45K	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$362.00	USD	2 Qtrs
Interest expense	`InterestExpense`	$19.28K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$846.00	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$6.75K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.81K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$18.00	USD	1 Quarter
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-821.25K	USD	1 Quarter
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.48M	USD	2 Qtrs
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.82M	USD	2 Qtrs
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.29M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-137.17K	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-87.83K	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-215.96K	USD	2 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-226.42K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-733.41K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-874.34K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.26M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-1.61M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-2.10M	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	2 Qtrs
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.20	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	2 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.52M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.52M	shares	2 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.00M	shares	2 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.41M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-733.41K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-874.34K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.26M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.61M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.10M	USD	1 Quarter
Depreciation	`Depreciation`	$484.00	USD	2 Qtrs
Depreciation	`Depreciation`	$4.22K	USD	2 Qtrs
Non-cash lease expense for right-of-use assets	`OperatingLeaseExpense`	$39.48K	USD	2 Qtrs
Non-cash lease expense for right-of-use assets	`OperatingLeaseExpense`	$41.32K	USD	2 Qtrs
Non-cash acquisition of in-process research and development	`NonCashAcquisitionOfInprocessResearchAndDevelopment`	-	USD	2 Qtrs
Non-cash acquisition of in-process research and development	`NonCashAcquisitionOfInprocessResearchAndDevelopment`	$300.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$2.14K	USD	2 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$397.66K	USD	2 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$397.66K	USD	2 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-215.96K	USD	2 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-226.42K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$192.53K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.17M	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	1 Quarter
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	1 Quarter
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$876.90K	USD	2 Qtrs
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-217.92K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-42.32K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-38.82K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$36.58K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$362.00	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.24K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-32.82K	USD	2 Qtrs
Due (from) to related parties	`IncreaseDecreaseInDueFromRelatedParties`	$26.81K	USD	2 Qtrs
Due (from) to related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-96.61K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-6.75K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$104.01K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$144.43K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-897.03K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.44M	USD	2 Qtrs
Net proceeds from private placement	`ProceedsFromIssuanceOfPrivatePlacement`	$9.88M	USD	2 Qtrs
Net proceeds from private placement	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	2 Qtrs
Borrowings on line of credit payable from related party	`BorrowingsOnLineOfCreditPayableFromRelatedParty`	-	USD	2 Qtrs
Borrowings on line of credit payable from related party	`BorrowingsOnLineOfCreditPayableFromRelatedParty`	$500.00K	USD	2 Qtrs
Proceeds received from our Paycheck Protection Program note payable	`ProceedsFromNotesPayable`	$162.46K	USD	2 Qtrs
Proceeds received from our Paycheck Protection Program note payable	`ProceedsFromNotesPayable`	-	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-4.31K	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-23.09K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.85M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$658.15K	USD	2 Qtrs
Net Increase (Decrease) in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-238.88K	USD	2 Qtrs
Net Increase (Decrease) in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.41M	USD	2 Qtrs
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.42M	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$452.65K	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$691.54K	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.83M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.42M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$452.65K	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$691.54K	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.83M	USD	Point-in-time

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$29.24M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$31.34M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$7.23M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$8.01M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$22.94M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$6.59M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$762.60K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$98.66K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$620.59K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$93.87K	USD	1 Quarter
Shares issued in private placement, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$446.48K	USD	2 Qtrs
Shares issued in private placement, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$9.88M	USD	1 Quarter
Shares issued in connection with license agreement	`StockIssuedDuringPeriodValueOther`	$300.00K	USD	1 Quarter
Stock dividend distributed due to full-ratchet anti-dilution adjustment	`StockDividendDistributedDueToFullratchetAntidilutionAdjustment`	-	USD	1 Quarter
Transaction costs related to anticipated 2020 offering	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$1.51K	USD	1 Quarter
Transaction costs related to anticipated 2020 offering	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$2.81K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-733.41K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-874.34K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.26M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.61M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.10M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$29.24M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$31.34M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$7.23M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$8.01M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$22.94M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$6.59M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.